Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Lambert-Eaton Myasthenic Syndrome
×
1 year
×
Clear all
Filters
3
NCT02189720
2025-03-26
EAP-001
Catalyst Pharmaceuticals, Inc.
Approved for marketing